Nvidia disclosed in recent regulatory filings that it had fully exited its roughly two‑year, 7.71 million‑share investment in Recursion Pharmaceuticals, while Cathie Wood’s ARK Invest simultaneously ...

Major investors Nvidia and Novo Holdings A/S have fully exited their positions in Recursion Pharmaceuticals (NasdaqGS:RXRX), signaling a shift in institutional backing. Recursion has acquired full ...

RXRX gears up for Q4 with $25.5 million revenue view as investors eye pipeline updates and REC-4881 progress ahead of FDA ...

Recursion will host a (L)earnings Call on February 25, 2026 at 8:00 am ET / 6:00 am MT / 1:00 pm GMT. The company will broadcast the live stream from Recursion’s X, LinkedIn, and YouTube accounts.

FDA truncates drug approval process; Makary pushes for more OTC drugs; Inside the rocky ride for Recursion Pharmaceuticals.

The OpenClaw episode exposed a risk most security programs are not actively watching for: collusion between AI-driven systems. In one of the first publicly observed instances, autonomous AI agents ...

Dead languages aren't as unimportant as they seem, because learning Latin, Sanskrit and Ancient Greek will make coding easier ...

The past is fast losing its reliability as a guide to the future in an age of exponentially evolving AI. As error rates drop ...

Wraithwatch, an AI cyber defense company founded by veterans of JSOC, Palantir, SpaceX, and Anduril, has been selected for a ...

An earlier 13F filing showed that the chipmaker held 7,716,050 shares of Applied Digital as of the end of September. ・Nvidia ...

If you were looking for me last Saturday evening, you’d have found me at the Irene and Alan Wurtzel Theater for the TIMARA faculty recital, titled “Signal: Noise.” The Wurtzel Theater’s vibe was ...

Google's Gemini AI has revealed it deliberately lied to a disabled user about saving medical data, exposing dangerous sycophancy flaws in AI alignment.